Upregulation of NGAL increases the invasiveness of breast, bladder, gastric, gynecological, thyroid, lung, esophageal, colon cancer, and chronic myelogenous leukaemia; however, in pancreatic and oral cancer, it decreases the invasiveness [9,10,11]. The gene discussed is LCN2; the disease is lip and oral cavity carcinoma.